3.53 USD
↗ 0.03 (0.71%)LIVE (AS OF 03:00 PM EDT)
Niagen Bioscience, Inc. Common Stock
NAGENASDAQ • USD
Market: OPEN
Shares of Niagen Bioscience, Inc. Common Stock (NAGE) are trading at $3.53. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (22.6%) and a bearish Death Cross on the long-term moving averages. Valuation metrics place NAGE at a fair price relative to peers.
Technical & fundamental data as of Jul 6, 2026.
Open?$3.58
High?$3.59
Low?$3.49
Prev. Close?$3.50
Volume?404.3K
Avg. Volume?787.5K
VWAP?$3.54
Rel. Volume?0.51x
Bid / Ask
Bid?$3.53 × 600
Ask?$3.54 × 800
Spread?$0.01
Midpoint?$3.54
Valuation & Ratios
Market Cap?278.8M
Shares Out?79.6M
Float?48.4M
Float %?60.5%
P/E Ratio?14.96
P/B Ratio?3.39
EPS?$0.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Employees
117
Market Cap
278.8M
Industry
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Website
Listed
2008-06-24
Address
10900 WILSHIRE BLVD
LOS ANGELES, CA 90024
Phone: 310-388-6706
LOS ANGELES, CA 90024
Phone: 310-388-6706
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?99
Momentum?23
Short Sent.?54
Piotroski F-Score?0/9Weak
Altman Z-Score?5.67Safe
Confidence?45%Low
Short InterestHigh
Short % of Float?9.29%Elevated
Short Interest?4.5M
Days to Cover?6.9
Free Float48.4M
Avg Daily Volume652.1K
Settlement Date2026-06-15
Financial Health
Current Ratio?4.61Strong
Quick Ratio?3.55Strong
Cash Ratio?2.92Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score78/100
P/E?15.0CHEAP▾
Peers100
S&P81
P/B?3.39FAIR▾
Peers100
S&P50
P/S?2.14CHEAP▾
Peers100
S&P63
P/FCF?67.9PRICEY▾
Peers100
S&P5
EV/EBITDA?15.2FAIR▾
Peers100
S&P49
EV/Sales?1.63CHEAP▾
Peers100
S&P82
Returns & Efficiency
ROE?22.6%STRONG▾
Peers50
S&P71
ROA?16.3%STRONG▾
Peers50
S&P90
Cash Flow & Enterprise
FCF?$4.1M
Enterprise Value?$212.2M
Fundamentals ratios updated end of day